Innovative/Translational Cancer Research Grants

Funding Agency:
Mary Kay Foundation

The Mary Kay Foundation, a funding source for cancer research, is currently accepting applications for innovative grants for translational research in ovarian, uterine, breast, or cervical cancer.

The program will offer grants up to $100,000 (combined direct and indirect costs - indirect costs cannot exceed 15%.) That may be used in a one-year period or up to two years. Applications must be submitted by one Principal Investigator, selected by the Institution. Grants are limited to the United States.

Only one grant application will be accepted from each invited cancer research institute or medical school. No exceptions.

This competition is only open to DCI members.

Deadlines:

  • Duke Internal: Dec. 9, 2019
  • Sponsor's Application Deadline: February 7, 2020

If you are interested in this funding opportunity, please submit the following information in one PDF to erin.carr@duke.edu by Monday, December 9th.

1.      NIH style biosketch for the applicant

2.      2 page description of project

3.    Draft budget and budget justification

Applications will be reviewed by the DCI’s Scientific Review Committee and applicants will be notified of the review outcome no later than December 20th.

Agency Website

Eligibility Requirements

The Principal Investigator that completes the applications must be Full-time Assistant Professor or higher at the time of application submission and the same person who signs the electronic signature. Names must match exactly.  Staff scientists, postdoctoral trainees and instructors are NOT eligible.

 

Amount

$100,000

Amount Description

The grant will be up to $100,000 (combined direct and indirect costs) for a two-year period.  If indirect costs are requested, they cannot exceed 15%.  If selected, the funds will be paid in two payments.  The first payment will be after receipt of the executed contract.  The second payment will be mailed following receipt of the first year status report.  The Foundation anticipates funding between ten and fifteen grants.

Funding Type

Grant

Duke Awardees

2004
Victoria Seewaldt, M.D.,
Duke University School of Medicine, associate professor, breast cancer research.
Will investigate genes involved in vitamin A processing to determine if their loss is associated with increased risk for developing breast cancer.

2003
Susan J. Littman, M.D., M.S
The Breast Cancer Susceptibility Gene, BRCA2: Isolation and Study of Its Biological Activity in DNA Repair.

Eligibility

Faculty
Junior Faculty

Category

Medical
Medical - Translational

Internal Nomination

If you are interested in this funding opportunity, please submit the following information in one PDF to erin.carr@duke.edu by Monday, December 9th.

1.      NIH style biosketch for the applicant

2.      2 page description of project

3.    Draft budget and budget justification

Applications will be reviewed by the DCI’s Scientific Review Committee and applicants will be notified of the review outcome no later than December 20th.

Internal Deadline

December 9, 2019

External Deadline

February 7, 2020